TACROCUTAN ong 0.03 % tb 30 g
7680692260017
CH-69226
D11AH01
10.04.0.
Reimbursement limitations:
PROTOPIC
Indiqué pour le traitement des formes modérées à sévères de la dermatite atopique, pour lesquels …
1 / 3
google
Details
- Product number
- 6922601
- CPT
- -
- Packaging group
- 30
- Unit
- g
- Composition
- tacrolimusum 0.3 mg ut tacrolimusum monohydricum, vaselinum album, E 307, paraffinum liquidum, propyleni carbonas, cera alba, paraffinum solidum, ad unguentum pro 1 g.
Articles (1)
Tacrocutan 0,03%, Salbe
Salbe
30
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.3 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTON |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 37.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
Dermapharm AG
6331 Hünenberg
Authorization information
- Swissmedic authorization number
- 69226
- Drug name
- Tacrocutan 0,03%, Salbe
- Galenic form
- SALB
- ATC Code
- D11AH01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/07/2024
- Authorization expiration date
- 03/07/2029
- IT number
- 10.04.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TACROCUTAN ong 0.03 % tb 30 g
- Description (DE)
- TACROCUTAN Salbe 0.03 % Tb 30 g
- Market launch
- 04/07/2024
- Narcotic (BTM)
- No